Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analysis of anti-Omicron neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
David J. Sullivan, Massimo Franchini, Michael J. Joyner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 15

Showing 15 citing articles:

Next-generation treatments: Immunotherapy and advanced therapies for COVID-19
Jenny Andrea Arévalo-Romero, Sandra M. Chingaté-López, Bernardo Camacho, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26423-e26423
Open Access | Times Cited: 8
Antiviral combination therapies for persistent COVID-19 in immunocompromised patients
Daniele Focosi, Fabrizio Maggi, Alessandra D’Abramo, et al.
International Journal of Infectious Diseases (2023) Vol. 137, pp. 55-59
Open Access | Times Cited: 17
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients
Sixten Körper, Beate Grüner, Daniel Zickler, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 24
Open Access | Times Cited: 21
Passive immunotherapies for COVID‐19: The subtle line between standard and hyperimmune immunoglobulins is getting invisible
Daniele Focosi, Massimo Franchini
Reviews in Medical Virology (2022) Vol. 32, Iss. 4
Closed Access | Times Cited: 14
Effectiveness of COVID-19 Convalescent Plasma (CCP) During the Pandemic Era: A Literature Review
Usha Rani Kandula, Techane Sisay Tuji, Dinkinesh Begna Gudeta, et al.
Journal of Blood Medicine (2023) Vol. Volume 14, pp. 159-187
Open Access | Times Cited: 7
A role for Nucleocapsid-specific antibody function in Covid-19 Convalescent plasma therapy
Jonathan D. Herman, Chuangqi Wang, John S. Burke, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 8
Reduced Mortality among COVID-19 ICU Patients after Treatment with HemoClear Convalescent Plasma in Suriname
Rosita Bihariesingh-Sanchit, Rakesh Bansie, Navin Ramdhani, et al.
mBio (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 4
Use of convalescent plasma in the treatment of COVID-19
Michael J. Joyner, Nigel Paneth, Arturo Casadevall
Nature Reviews Nephrology (2023) Vol. 19, Iss. 4, pp. 271-271
Open Access | Times Cited: 3
Neutralizing antibody levels against SARS‐CoV‐2 variants of concern Delta and Omicron in vaccine breakthrough‐infected blood donors
Massimo Franchini, Daniele Focosi, Carlo Mengoli, et al.
Transfusion (2022) Vol. 62, Iss. 6, pp. 1171-1176
Closed Access | Times Cited: 5
Convalescent Plasma Therapy against COVID-19: An Update on the Changing Facets of the ongoing Pandemic
Saquib S. Abullais, Suraj Arora, Shadma Wahab, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 24, Iss. 12, pp. 1515-1523
Closed Access | Times Cited: 2
Understanding the parameters guiding the best practice for treating B‐cell‐depleted patients with COVID‐19 convalescent plasma therapy
David Gachoud, Claire Bertelli, Nathalie Rufer
British Journal of Haematology (2022) Vol. 200, Iss. 2
Open Access | Times Cited: 4
Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021
Yi-Chan Lin, David H. Evans, Ninette F Robbins, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 1
Convalescent plasma in oncohematological patients
Daniele Focosi, Massimo Franchini, Michael J. Joyner, et al.
Hematological Oncology (2022) Vol. 41, Iss. 1, pp. 208-209
Open Access | Times Cited: 2
SARS-CoV-2 Omicron Variant AI-based Primers
Carmina Angelica Perez-Romero, Alberto Tonda, Lucero Mendoza‐Maldonado, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Commentary on “Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study”
Michael J. Joyner, Nigel Paneth
mBio (2022) Vol. 13, Iss. 6
Open Access
Page 1

Scroll to top